Catalyst Wire Dossier Catalyst Wire Dossier

Afstyla

eftrenonacog alfa
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Afstyla, covering 2025-01-08 to 2025-12-11. Get the full timeline:

Most recent: EMA Authorised: Afstyla (lonoctocog alfa) — CSL Behring GmbH

See pricing